Skip to main content
CNOCNO Financial Group, Inc.Sell5.6·$49.97+0.69%
Open full analysis

CNO Financial Group, Inc. (CNO) Stock Analysis

Breakout setup

SellVALUE-TRAP 2/5Moderate Confidence

Financial Services · Insurance - Life

Sell if holding. Analyst target reached at $49.97 — A.R:R is negative (-1.8) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Counterparty: top-7 reinsurers.

CNO Financial Group markets health insurance, annuities and individual life insurance to middle-income pre-retirees and retirees across all 50 states through three brands: Bankers Life, Washington National and Colonial Penn. The company collected $4.6 billion in premiums in 2025... Read more

$49.97-1.5% A.UpsideScore 5.6/10#10 of 15 Insurance - Life
QualityF-score8 / 9FCF yield22.15%
IncomeYield1.45%(5y avg 2.06%)Payout27.42%sustainable
Stop $48.27Target $49.20(resistance)A.R:R -1.8:1
Analyst target$49.50-0.9%4 analysts
$49.20our TP
$49.97price
$49.50mean
$47
$53

Sell if holding. Analyst target reached at $49.97 — A.R:R is negative (-1.8) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Counterparty: top-7 reinsurers. Chart setup: Golden cross, above all MAs, RSI 70, MACD bullish. Score 5.6/10, moderate confidence.

Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 46d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-12

Recent Developments — CNO Financial Group, Inc.

Generated 2026-06-15T18:11:46Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Mon, Jul 27, 202646d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
Attractive valuation
Positive momentum
Risks
Concentration risk — Counterparty: top-7 reinsurers
Analyst target reached - limited upside remaining
Near 52-week high (-0.0% away)

Key Metrics

P/E (TTM)20.0
P/E (Fwd)10.0
Mkt Cap$4.6B
EV/EBITDA7.8
Profit Mgn5.4%
ROE9.8%
Rev Growth2.5%
Beta0.84
Dividend1.45%
Rating analysts13

Quality Signals

Piotroski F8/9

Options Flow

P/C0.32bullish
IV68%elevated

Concentration Risks(10-K Item 1A)

  • MEDIUMProductfixed indexed annuities38%
    10-K Item 1: 'Fixed Indexed Annuities. These products accounted for $1,739.9 million, or 38 percent, of our total premium collections during 2025.'
  • LOWGeographicFlorida12%
    10-K Item 1: 'Sales to residents of the following states accounted for at least 5 percent of our 2025 collected premiums: Florida (12 percent)'
  • HIGHcounterpartytop-7 reinsurers
    10-K Item 1A: 'Our seven largest reinsurers...accounted for 97 percent of our ceded life insurance inforce and 99 percent of our reinsurance receivables.'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Value Rank
2.5
Growth Rank
2.7
Quality Rank
3.3

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.0
Support Resistance
0.5
52w Position
9.9
GatesA.R:R -1.8=NEGATIVEMomentum 7.2>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 46d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Aggressive
RSI
70 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $45.63Resistance $50.20

Price Targets

$48
$49
A.Upside-1.5%
A.R:R-1.8:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-15.8% upside)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-27 (46d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CNO stock a buy right now?

Sell if holding. Analyst target reached at $49.97 — A.R:R is negative (-1.8) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Counterparty: top-7 reinsurers. Chart setup: Golden cross, above all MAs, RSI 70, MACD bullish. Prior stop was $48.27. Score 5.6/10, moderate confidence.

What is the CNO stock price target?

Take-profit target: $49.20 (-1.5% upside). Prior stop was $48.27. Stop-loss: $48.27.

What are the risks of investing in CNO?

Concentration risk — Counterparty: top-7 reinsurers; Analyst target reached - limited upside remaining; Near 52-week high (-0.0% away).

Is CNO overvalued or undervalued?

CNO Financial Group, Inc. trades at a P/E of 20.0 (forward 10.0). TrendMatrix value score: 7.6/10. Verdict: Sell.

What do analysts say about CNO?

13 analysts cover CNO with a consensus score of 2.6/5. Average price target: $50.

What does CNO Financial Group, Inc. do?CNO Financial Group markets health insurance, annuities and individual life insurance to middle-income pre-retirees and...

CNO Financial Group markets health insurance, annuities and individual life insurance to middle-income pre-retirees and retirees across all 50 states through three brands: Bankers Life, Washington National and Colonial Penn. The company collected $4.6 billion in premiums in 2025 with $38.8 billion in total assets, earning spread income primarily on fixed indexed annuities, which accounted for 38% of total premium collections.

Related stocks: FG (F&G Annuities & Life, Inc.) · PRI (Primerica, Inc.) · PUK (Prudential Public Limited Compa) · LNC (Lincoln National Corporation) · GL (Globe Life Inc.)
Home Stocks CNO

Latest news

Latest News

Benzinga14d agoAnalyst
Benzinga14d agoAnalyst
Benzinga15d agoAnalyst
Benzinga27d ago
Benzinga41d agoAnalyst
Benzinga45d agoEarnings
Benzinga46d ago
Benzinga46d agoEarnings